<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00329095</url>
  </required_header>
  <id_info>
    <org_study_id>GMED-01</org_study_id>
    <nct_id>NCT00329095</nct_id>
  </id_info>
  <brief_title>An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance</brief_title>
  <official_title>An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robin, Alan L., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Robin, Alan L., M.D.</source>
  <brief_summary>
    <textblock>
      This is an open-label study in patients who are currently using either a topical
      prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin
      plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the
      same eye(s). Compliance will be measured over the two months of participation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label study in patients who are currently using either a topical
      prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin
      plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the
      same eye(s). Compliance will be measured over the two months of participation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date>April 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance.</measure>
  </primary_outcome>
  <enrollment>60</enrollment>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>travoprost, latanoprost, or bimatoprost</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Additional ocular hypotensive medication</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Currently using one or two topical ocular hypotensive medications

        Exclusion Criteria:

          -  Hypersensitivity to any component of medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan L. Robin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alan L. Robin, M.D.</affiliation>
  </overall_official>
  <verification_date>May 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2006</study_first_submitted>
  <study_first_submitted_qc>May 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2006</study_first_posted>
  <last_update_submitted>May 22, 2006</last_update_submitted>
  <last_update_submitted_qc>May 22, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2006</last_update_posted>
  <keyword>Glaucoma</keyword>
  <keyword>Compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Latanoprost</mesh_term>
    <mesh_term>Bimatoprost</mesh_term>
    <mesh_term>Travoprost</mesh_term>
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

